Outcubation-where incubation meets outsourcing

Nature Biotechnology

Volumn 33, Issue 1, 2015, Pages 20-21

  Betz, Ulrich A K ^a   Tidona, Christian A ^b  

^a Merck Serono GmbH   (Germany)

^b BioMed X Innovation Center   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CAPITAL; COMMERCIAL PHENOMENA; CROWDSOURCING; DRUG INDUSTRY; FINANCIAL MANAGEMENT; INCUBATION; INTERNALIZATION; LEADERSHIP; LETTER; LICENSING; MARKETING; MODEL; MOLECULAR BIOLOGY; ORGANIZATION; ORGANIZATION AND MANAGEMENT; OUTCUBATION; PATENT; PRIORITY JOURNAL; RESOURCE ALLOCATION;

CONTRACT SERVICES; DECISION MAKING, ORGANIZATIONAL; DRUG INDUSTRY; ORGANIZATION AND ADMINISTRATION;

EID: 84963978327     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt.3112     Document Type: Letter

References (9)

1. Anonymous. Nat. Biotechnol. 32, 109 (2014).
2. Schuhmacher, A. et al. Drug Discov. Today 18, 1133-1137 (2013).
3. Chesbrough, H.W. Open Innovation: The New Imperative for Creating and Profiting from Technology (Harvard Business School Press, 2003).
4. Getz, K., Kaitin, K. Expert Rev. Clin. Pharmacol. 5, 481-483 (2012).
5. Hunter, J., Stephens, S. Nat. Rev. Drug Discov. 9, 87-88 (2010).
6. Comanor, W. et al. J. Health Econ. 32, 106-113 (2013).
7. Stokes, D. Pasteur's Quadrant: Basic Science and Technological Innovation (Brookings Institution Press, 1997).
8. Dugan, R., Gabriel, K. Harvard Business Review, (October 2013) https://hbr.org/2013/10/special-forces-innovation-how-darpa-attacks-problems.
9. Emmert-Buck, M. J. Transl. Med. 9, 54-57 (2011).